TY - JOUR
T1 - Clinical Features of Pediatric Uveitis at a Tertiary Referral Center in the Western Region of Japan
AU - Fukuda, Yosuke
AU - Yawata, Nobuyo
AU - Hasegawa, Eiichi
AU - Yamana, Satoshi
AU - Shirane, Mariko
AU - Ito, Takako
AU - Takeda, Atsunobu
AU - Sonoda, Motoshi
AU - Eguchi, Katsuhide
AU - Ishimura, Masataka
AU - Ohga, Shouichi
AU - Sonoda, Koh Hei
N1 - Publisher Copyright:
© 2023 Taylor & Francis Group, LLC.
PY - 2023
Y1 - 2023
N2 - Purpose: This study aimed to assess the clinical features of pediatric uveitis at a tertiary referral center in Western Japan. Methods: One hundred forty eyes of 80 patients aged <20 years at the time of uveitis onset, who visited Kyushu University Hospital between January 2010 and December 2019 were included in this study. Clinical records were retrospectively reviewed. Demographics, clinical findings, treatments, and visual prognoses were compared between the disease groups. Results: Of 80 patients, 32 were males and 48 were females. The average age of onset was 12.5 ± 4.8 (0–19) years. Tubulointerstitial nephritis and uveitis (TINU) and juvenile idiopathic arthritis (JIA) were the most frequent causes, accounting for 11.3% and 10% of cases, respectively, followed by sarcoidosis (5%), Behçet’s disease, acute anterior uveitis, Vogt-Koyanagi-Harada disease, and juvenile chronic iridocyclitis (3.8% each). Infectious uveitis accounted for 7.6% of the cases: cytomegalovirus was the most frequent agent. Of these cases, 43.8% were unclassified. Systemic therapies were administered to 87.5% of the patients with JIA, 33.3% of those with TINU, and 28.6% of the other diagnostic groups. In the unclassified group, 80% of the patients were followed up with only topical corticosteroids. LogMAR visual acuity of 0 or less accounted for more than 80% in the final examination. Conclusion: TINU and JIA were the most common causes of pediatric uveitis. Although each required systemic therapy, most unclassified cases of pediatric uveitis were managed by topical corticosteroids alone with good visual prognosis. Accurate diagnosis is important for pediatric uveitis management.
AB - Purpose: This study aimed to assess the clinical features of pediatric uveitis at a tertiary referral center in Western Japan. Methods: One hundred forty eyes of 80 patients aged <20 years at the time of uveitis onset, who visited Kyushu University Hospital between January 2010 and December 2019 were included in this study. Clinical records were retrospectively reviewed. Demographics, clinical findings, treatments, and visual prognoses were compared between the disease groups. Results: Of 80 patients, 32 were males and 48 were females. The average age of onset was 12.5 ± 4.8 (0–19) years. Tubulointerstitial nephritis and uveitis (TINU) and juvenile idiopathic arthritis (JIA) were the most frequent causes, accounting for 11.3% and 10% of cases, respectively, followed by sarcoidosis (5%), Behçet’s disease, acute anterior uveitis, Vogt-Koyanagi-Harada disease, and juvenile chronic iridocyclitis (3.8% each). Infectious uveitis accounted for 7.6% of the cases: cytomegalovirus was the most frequent agent. Of these cases, 43.8% were unclassified. Systemic therapies were administered to 87.5% of the patients with JIA, 33.3% of those with TINU, and 28.6% of the other diagnostic groups. In the unclassified group, 80% of the patients were followed up with only topical corticosteroids. LogMAR visual acuity of 0 or less accounted for more than 80% in the final examination. Conclusion: TINU and JIA were the most common causes of pediatric uveitis. Although each required systemic therapy, most unclassified cases of pediatric uveitis were managed by topical corticosteroids alone with good visual prognosis. Accurate diagnosis is important for pediatric uveitis management.
UR - http://www.scopus.com/inward/record.url?scp=85175805064&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85175805064&partnerID=8YFLogxK
U2 - 10.1080/09273948.2023.2273363
DO - 10.1080/09273948.2023.2273363
M3 - Article
C2 - 37917805
AN - SCOPUS:85175805064
SN - 0927-3948
VL - 31
SP - 2032
EP - 2038
JO - Ocular Immunology and Inflammation
JF - Ocular Immunology and Inflammation
IS - 10
ER -